High rate of febrile neutropenia in patients with operable breast cancer receiving docetaxel and cyclophosphamide von Soong, Derrick, Haj, Reem, Leung, Mova G, Myers, Robert, Higgins, Brian, Myers, Jeff, Rajagopal, Sudha

Volltext

Developing recommendations for the safe handling of oral anti-cancer drugs in community pharmacies: A pan-Canadian consensus approach von Vu, Kathy, Emberley, Philip, Brown, Erika, Abbott, Rick, Bates, Justin, Bourrier, Venetia, Djordjevic, Kathryn, Greenall, Julie, Leung, Mova, Pasetka, Mark, Paquet, Louise, Logan, Heather

Volltext

Recommendations for the safe use and handling of oral anticancer drugs in community pharmacy: A pan-Canadian consensus guideline von Vu, Kathy, Emberley, Philip, Brown, Erika, Abbott, Rick, Bates, Justin J., Bourrier, Venetia, Djordjevic, Kathryn, Greenall, Julie, Leung, Mova, Pasetka, Mark, Paquet, Louise, Logan, Heather

Volltext

PIK3CA Inhibitor, Alpelisib, and Diabetic Ketoacidosis: A Lesson on Choosing Wisely von Leung, Mova, Roitman, Daryl

Volltext

Ketoacidosis in a Patient with Type 2 Diabetes Requiring Alpelisib: Learnings and Observations Regarding Alpelisib Initiation and Rechallenge von Leung, Mova, Rodrigues, Paulina, Roitman, Daryl

Volltext

Should the concomitant use of erlotinib and acid-reducing agents be avoided? The drug interaction between erlotinib and acid-reducing agents von Duong, Silvia, Leung, Mova

Volltext

A modified filgrastim regimen does not reduce pain burden compared to pegfilgrastim in women receiving chemotherapy for non-metastatic breast cancer von Leung, Mova, Florendo, Joy, Kano, Jessica, Marr-Del Monte, Tiffany, Higgins, Brian, Myers, Robert, Menon, Trishala, Jones, Glenn

Volltext

Pain severity and impairment of activity between pegfilgrastim (P) and fixed-dose filgrastim (F) in women with early-stage breast cancer receiving chemotherapy von Leung, Mova, Eustaquio, Joy, Kano, Jessica, Marr, Tiffany, Higgins, Brian Patrick, Myers, Robert Edward, Kim, Jenny, Jones, Glenn

Volltext

Ketoacidosis in a Patient with Type 2 Diabetes Requiring Alpelisib: Learnings and Observations Regarding Alpelisib Initiation and Rechallenge von Leung, Mova, Rodrigues, Paulina, Roitman, Daryl

Volltext

Lifestyle intervention or treatment with metformin. Which delays onset of type 2 diabetes? von Leung, Mova, Kwan, Debbie, Evans, Michael F

Volltext

Placebos von Holbrook, Anne, Goldsmith, Charles H, Leung, Mova

Volltext